Study record managers: refer to the Data Element Definitions if submitting registration or results information.
|1||NCT00813293||Active, not recruiting||Sorafenib Therapy Prior to Radiofrequency Ablation for Intermediate Sized Hepatocellular Cancer||
||Other / Industry / NIH||
||20||All||18 Years and older (Adult, Senior)||NCT00813293||08-256
|January 2009||December 2016||December 2017||December 23, 2008||February 27, 2017||